[The role of leukocytes in the increased vessel permeability in inflammation].
Klimenko
N A
NA
Pavlova
E A
EA
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D002199:Capillary Permeability; D002351:Carrageenan; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D007249:Inflammation / Q000473:pathology*; D007958:Leukocyte Count; D007962:Leukocytes / Q000473:pathology*; D007970:Leukopenia / Q000150:complications / Q000473:pathology; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology; D008247:Lysosomes / Q000201:enzymology; D008297:Male; D010538:Peritonitis / Q000139:chemically induced / Q000150:complications / Q000473:pathology; D011480:Protease Inhibitors / Q000494:pharmacology; D011839:Radiation, Ionizing; D051381:Rats; D017208:Rats, Wistar; D017382:Reactive Oxygen Species / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D016861:Cyclooxygenase Inhibitors; D016859:Lipoxygenase Inhibitors; D011480:Protease Inhibitors; D017382:Reactive Oxygen Species; D003907:Dexamethasone; D002351:Carrageenan